DE231092C - - Google Patents
Info
- Publication number
- DE231092C DE231092C DENDAT231092D DE231092DA DE231092C DE 231092 C DE231092 C DE 231092C DE NDAT231092 D DENDAT231092 D DE NDAT231092D DE 231092D A DE231092D A DE 231092DA DE 231092 C DE231092 C DE 231092C
- Authority
- DE
- Germany
- Prior art keywords
- compounds
- acid
- oxymercury
- ammonia
- amines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 10
- 150000008064 anhydrides Chemical class 0.000 claims description 7
- 150000001412 amines Chemical class 0.000 claims description 5
- -1 amino fatty acids Chemical class 0.000 claims description 5
- 229910021529 ammonia Inorganic materials 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- 150000001735 carboxylic acids Chemical class 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 230000007935 neutral effect Effects 0.000 claims description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 125000001841 imino group Chemical group [H]N=* 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 5
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- CJNZAXGUTKBIHP-UHFFFAOYSA-N 2-iodobenzoic acid Chemical class OC(=O)C1=CC=CC=C1I CJNZAXGUTKBIHP-UHFFFAOYSA-N 0.000 description 2
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229960002319 barbital Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910000474 mercury oxide Inorganic materials 0.000 description 2
- IOQKJDCMPKUNQN-UHFFFAOYSA-L mercury(2+);2-oxidobenzoate Chemical compound C1=CC=C2C(=O)O[Hg]OC2=C1 IOQKJDCMPKUNQN-UHFFFAOYSA-L 0.000 description 2
- UKWHYYKOEPRTIC-UHFFFAOYSA-N mercury(ii) oxide Chemical compound [Hg]=O UKWHYYKOEPRTIC-UHFFFAOYSA-N 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- QSACCXVHEVWNMX-UHFFFAOYSA-N N-acetylanthranilic acid Chemical compound CC(=O)NC1=CC=CC=C1C(O)=O QSACCXVHEVWNMX-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- WRYNUJYAXVDTCB-UHFFFAOYSA-M acetyloxymercury Chemical compound CC(=O)O[Hg] WRYNUJYAXVDTCB-UHFFFAOYSA-M 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- RCTYPNKXASFOBE-UHFFFAOYSA-M chloromercury Chemical compound [Hg]Cl RCTYPNKXASFOBE-UHFFFAOYSA-M 0.000 description 1
- DGJMPUGMZIKDRO-UHFFFAOYSA-N cyanoacetamide Chemical compound NC(=O)CC#N DGJMPUGMZIKDRO-UHFFFAOYSA-N 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- QGBSISYHAICWAH-UHFFFAOYSA-N dicyandiamide Chemical compound NC(N)=NC#N QGBSISYHAICWAH-UHFFFAOYSA-N 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
- 229940091173 hydantoin Drugs 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 150000002731 mercury compounds Chemical class 0.000 description 1
- QFAXIZQBSCGJMA-UHFFFAOYSA-N mercury;hydrate Chemical compound O.[Hg] QFAXIZQBSCGJMA-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- ZFLIKDUSUDBGCD-UHFFFAOYSA-N parabanic acid Chemical compound O=C1NC(=O)C(=O)N1 ZFLIKDUSUDBGCD-UHFFFAOYSA-N 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/10—Mercury compounds
- C07F3/12—Aromatic substances containing mercury
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
KAISERLICHESIMPERIAL
PATENTAMT.PATENT OFFICE.
PATENTSCHRIFTPATENT LETTERING
- JVl 231092 -KLASSE \2q. GRUPPE - JVl 231092 - CLASS \ 2q. GROUP
Das in der Therapie verwandte salicylsäure Quecksilberoxyd (Hydrargyrum salicylicum) des deutschen Arzneibuches hat für seine Verwendung den großen Nachteil, daß es in Wasser kaum löslich ist (Hagers Handbuch der Pharmazeutischen Praxis, Neue Bearb., Bd. II, S. 64).The salicylic acid mercury oxide (Hydrargyrum salicylicum) des The major disadvantage of the German pharmacopoeia for its use is that it is hardly soluble in water (Hagers Handbuch der Pharmaceuticals Practice, New Ed., Vol. II, p. 64).
Es wurde nun gefunden, daß man mit Hilfe dieses Körpers sowie anderer Oxyqueck-It has now been found that with the help of this body and other Oxyqueck-
1.0 silbercarbonsäuren bzw. ihrer Anhydride oder Derivate Quecksilberpräparate herstellen kann, die sich vor den Ausgangsstoffen dadurch auszeichnen, daß sie keinerlei Reiz- und Ätzwirkungen ausüben und dabei die besondere Wirkung der Oxyquecksilbercarbonsäuren in vollem Umfange besitzen. Die neuen Produkte sind daher wertvolle therapeutische Mittel und besonders deshalb von Bedeutung, weil sie zur subkutanen Injektion in hervorragender Weise geeignet sind. Das Verfahren zur Darstellung dieser neuen Produkte besteht darin, daß man diese Säuren bzw. ihre Anhydride oder Derivate mit Ammoniak oder organischen Aminen und den in den Patenten 224435, 224864 und 227391 erwähnten stickstoffhaltigen Körper, wie Aminosäuren, Säureamiden, Säureimiden, Eiweißkörpern, behandelt. 1.0 can produce silver carboxylic acids or their anhydrides or derivatives, which are distinguished from the starting materials in that they do not have any irritating or corrosive effects exercise and have the special effect of the oxymercury carboxylic acids in full. The new products are therefore valuable therapeutic agents and are therefore particularly important because they are excellently suited for subcutaneous injection. The procedure to represent these new products is that you these acids or their Anhydrides or derivatives with ammonia or organic amines and those in the patents 224435, 224864 and 227391 mentioned nitrogenous bodies, such as amino acids, acid amides, Acidimides, protein bodies, treated.
Die neuen Produkte sind bedeutend leichter löslich und wirken weit weniger ätzend als die entsprechenden Verbindungen aus Ammoniak oder Aminen allein. Außerdem sind sie beständiger gegen die Kohlensäure der Luft und daher zur therapeutischen Verwendung besser geeignet. ·The new products are significantly more soluble and are far less corrosive than the corresponding compounds from ammonia or amines alone. They are also more resistant to carbon dioxide Air and therefore more suitable for therapeutic use. ·
336 Teile Hydrargyrum salicylicum werden in 1500 Teilen Wasser suspendiert, mit 89 Teilen Alanin und dann so lange mit einer konzentrierten wässerigen Lösung von Äthylendiamin versetzt, bis Lösung eingetreten ist. Nach dem Filtrieren wird das Salz durch Eindampfen im Vakuum kristallinisch abgeschieden. Es ist in Wasser sehr leicht löslich und reagiert auf Phenolphtalein fast neutral. Säuren zersetzen es unter Abscheidung des Quecksilbersalicylats. Die Doppelverbindung ist unlöslich in Alkohol, Äther und Benzol.336 parts of Hydrargyrum salicylicum are suspended in 1500 parts of water, with 89 parts Alanine and then so long with a concentrated aqueous solution of ethylenediamine added until solution has occurred. After filtering, the salt is precipitated in crystalline form by evaporation in vacuo. It is very easily soluble in water and has an almost neutral reaction to phenolphthalein. Acids decompose it with the separation of the mercury salicylate. The double connection is insoluble in alcohol, ether and benzene.
105 Teile Quecksilbersalicylat - Piperidinverbindung werden in 500 Teilen Wasser suspendiert und 25 Teile Succinimid zugegeben. Hierbei tritt sofort Lösung ein unter Bildung des Doppelsalzes. Dieses wird durch Abdampfen des Wassers im luftverdünnten Raum in kristallinischer Form zur Abscheidung gebracht. Es ist in Wasser im Gegensatz der Quecksilbersalicylat - Piperidin verbindung selbst ungemein leicht löslich. Seine Lösung reagiert gegen Phenolphtalein neutral und wird durch die Kohlensäure der Luft nicht verändert. Starke Säuren zersetzen das Salz unter Abscheidung des Quecksilbersalicylats; in organischen Lösungsmitteln ist es unlöslich.105 parts of mercury salicylate - piperidine compound are suspended in 500 parts of water and 25 parts of succinimide are added. In this case, solution occurs immediately with formation of the double salt. This is done by evaporating the water in the air-diluted room brought to the deposition in crystalline form. It is in contrast to the water Mercury salicylate - piperidine compound itself is extremely soluble. His solution reacts neutral to phenolphthalein and is not changed by the carbonic acid in the air. Strong acids decompose the salt with the separation of the mercury salicylate; in organic It is insoluble in solvents.
100 Teile Oxymercuri-m-oxybenzoesäureanhydrid (durch Kochen von Quecksilberoxyd mit m - Oxy benzoesäure in wässeriger Lösung dargestellt) und 55 Teile Diäthylbarbitursäure werden in Wasser verteilt und bis zur Losung mit Piperidin versetzt. Nach dem Filtrieren wird die Lösung bei niedriger Temperatur in luftverdünntem Raum zur Trockne gebracht. Das Mercuri-m-oxybenzoesäurepiperidin ist in Wasser leicht löslich, unlöslich dagegen in Äther, Benzol und Chloroform.100 parts of oxymercuri-m-oxybenzoic anhydride (represented by boiling mercury oxide with m-oxybenzoic acid in an aqueous solution) and 55 parts of diethylbarbituric acid are distributed in water and mixed with piperidine until the solution is dissolved. After filtering the solution is brought to dryness at low temperature in an air-diluted room. Mercuri-m-oxybenzoic acid piperidine is easily soluble in water, but insoluble in Ether, benzene and chloroform.
Das Verfahren verläuft in analoger Weise bei Verwendung anderer Oxyquecksilbercarbonsäuren bzw. ihrer Anhydride oder ihrer Derivate, wie Oxyquecksilbernaphtolcarbonsäuren, Oxyquecksilberjodbenzoesäuren, Oxyquecksilberacetylanthranilsäure, Ammoniak, anderer Amine, wie Piperazin, Tetramethylendiamin, Dimethylamin oder anderer der erwähnten Stickstoffverbindungen, wie Glykokoll, ß-Aminooxyisobuttersäure, Dicyandiamid, Harnstoff, Diäthylbarbitursäure, . Cyanacetamid, Eiweißkörper, Oxalylharnstoff, Hydantoin.The process proceeds in an analogous manner when using other oxymercuric carboxylic acids or their anhydrides or their derivatives, such as oxymercury naphtholecarboxylic acids, Oxymercury iodobenzoic acids, oxymercury acetylanthranilic acid, Ammonia, other amines such as piperazine, tetramethylenediamine, dimethylamine or others of those mentioned Nitrogen compounds such as glycocolla, ß-aminooxyisobutyric acid, dicyandiamide, urea, Diethylbarbituric acid,. Cyanoacetamide, protein bodies, oxalylurea, hydantoin.
Das Oxymercuri - 0 - j odbenzoesäureanhydrid wird erhalten durch Erhitzen von Quecksilberoxyd mit o-Jodbenzoesäure im Überschuß auf 170 °, bis die Schmelze in Natronlauge klar löslich ist.The oxymercuri-0-iodobenzoic anhydride is obtained by heating mercury oxide with o-iodobenzoic acid in excess to 170 ° until the melt in sodium hydroxide solution is clearly soluble.
Oxymercuriacetylanthranilsäureanhydrid und Oxymercuri -1- naphtol - 2 - carbonsäureanhydrid werden erhalten durch Erhitzen der Säuren mit Quecksilberacetat in essigsaurer Lösung.Oxymercuriacetylanthranilic anhydride and oxymercuri-1-naphthol-2-carboxylic anhydride are obtained by heating the acids with mercury acetate in acetic acid solution.
Diese Quecksilberverbindungen sind alle unlöslich in Wasser und organischen Lösungsmitteln, leicht löslich in Alkalien. Gegen verdünnte Schwefelsäure und Salpetersäure sind sie sehr beständig; durch Salzsäure werden sie in Quecksilberchlorid und die entsprechende Säure gespalten.These mercury compounds are all insoluble in water and organic solvents, easily soluble in alkalis. Against dilute sulfuric acid and nitric acid are she is very persistent; by hydrochloric acid they are converted into mercury chloride and the corresponding Split acid.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE231092C true DE231092C (en) |
Family
ID=491241
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT231092D Active DE231092C (en) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE231092C (en) |
-
0
- DE DENDAT231092D patent/DE231092C/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0612322B1 (en) | Method of separating the enantiomers of 5-methyl-tetrahydrofolic acid | |
| DE1620024B2 (en) | 3'-pyridylmethyl-2- (4-chlorophenoxyy2-methylpropionate | |
| DE231092C (en) | ||
| DE1795151C3 (en) | 7-square bracket on D-alpha-amino- (3-actamidophenylacetamido) square bracket on -cephalosporanic acid | |
| DE2166270C3 (en) | Nicotinoylaminoethanesulfonyl-2amino-thiazole | |
| DE2500802A1 (en) | N-ACYL (ALPHA AND BETA) ASPARAGYL GLUTAMIC ACIDS AND THEIR SALTS, PROCESS FOR THEIR PREPARATION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS | |
| DE1229543B (en) | Process for the preparation of 1, 3-dithia-2-arsacyclopentane-4, 5-dicarboxylic acids | |
| DE633786C (en) | Process for the preparation of complex compounds of 1,3-dimethylxanthine | |
| DE165898C (en) | ||
| DE2107866B2 (en) | THIAMPHENICOL DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND ANTIBACTERIAL AGENT | |
| DE301870C (en) | ||
| DE254502C (en) | ||
| DE939929C (en) | Process for the preparation of a molecular compound of 1-phenyl-2,3-dimethyl-4-dimethylamino-5-pyrazolone | |
| DE2405652C3 (en) | 3,6,9-trioxaundecane-1,11 -dioyl-bis- (3-carboxy-2,4,6-triiodo-anilide), its salts with physiologically acceptable bases, processes for the preparation of these compounds and X-ray contrast media containing these compounds | |
| DE139907C (en) | ||
| EP0006151B1 (en) | Process for preparing 17-hydroxyspartein | |
| AT147483B (en) | Process for the preparation of compounds of methyl N-methyltetrahydronicotinate. | |
| DE2433889C2 (en) | Process for the production of pure allcls-cyclopentane-1,2,3,4-tetracarboxylic acid or its salts | |
| DE264267C (en) | ||
| DE1470357C (en) | 1 (3 Dimethylammopropyl) 4 myristoyl amidopiperidine, its acid addition salts and process for their preparation | |
| DE2027832C3 (en) | Process for the production of thiamphenicol glycinate acetylcysteinate | |
| CH498089A (en) | Prodn of amino acid salts of glutathione | |
| DE281912C (en) | ||
| DE454701C (en) | Process for the preparation of derivatives of arsenostibiobenzene which are symmetrically disubstituted in the 3,4-position | |
| DE234631C (en) |